INFO
Bio Retina – Retinal Prosthesis- Regenerative – Protective- Biophysical- Laser- Surgical-Medical-Rehabilitative Therapies for Retina

Doç. Dr. Umut Arslan

Göz Doktoru
Neorama Ofis
Beştepe Mahallesi, Yaşam Cd. No:13/A Neorama Ofis 56 (Akparti Genel Merkezi ve TOBB ETÜ Hastanesi Yanı) Söğütözü / ANKARA

Doğum Yeri ve Tarihi: ANTAKYA / 1978

Öğrenim Süreci:

İLK-ORTA-LİSE ÖĞRENİMİ: ANTAKYA / 1994
ÜNİVERSİTE: İSTANBUL ÜNİVERSİTESİ İSTANBUL TIP FAKÜLTESİ / 1994-2000
UZMANLIK: ANKARA ÜNİVERSİTESİ TIP FAKÜLTESİ GÖZ HASTALIKLARI ANABİLİM DALI / 2000-2004

Katıldığı veya Yürüttüğü Projeler:

BİORETİNA BİYOTEKNOLOJİ BİYOMEDİKAL SAĞLIK YATIRIMLARI A.Ş KURUCU ORTAĞIDIR.

1) RETİNİTİS PİGMENTOSA VE RETİNA İSKEMİSİ YAPAN HASTALIKLARIN TEDAVİSİNDE, SUBTENON OTOLOG PLATELETTEN ZENGİN PLAZMA (PRP) VE GROWTH FAKTÖR UYGULAMALARI

2) RETİNİTİS PİGMENTOSA VE RETİNA İSKEMİSİ YAPAN HASTALIKLARIN TEDAVİSİNDE, MEZENKİMAL KÖK HÜCRE ARAŞTIRMA VE UYGULAMALARI

3) RETİNA HASTALIKLARININ TEDAVİSİNDE RETİNAL VE OKSİPİTAL KORTEKS STİMÜLASYON ARAŞTIRMALARI (PATENTLİ CİHAZ ARAŞTIRMALARI)

4) AZ GÖRME REHABİLİTASYON ARAÇLARI AR-GE VE ÜRETİMİ

Dr.Umut ARSLAN

Ophthalmologist, Retina Specialist,

Regenerative ophthalmologist

Education

University: Istanbul University, Faculty of Medicine / 1994-2000

Speciality: Ankara University, Faculty of Medicine, Department of Ophthalmology / 2000-2004

His specialty is regenerative, restorative, stem cell, growth factors and electromagnetic stimulation applications in the treatment of retinal and optic nerve diseases.

ORCID: 0000-0003-4146-8083

Employment

Ankara Üniversitesi: Ankara, Ankara, TR

Researcher (Technology Research and Development Center)

Employment

Education and qualifications

Ankara Üniversitesi: Ankara, Ankara, TR

MD (Faculty of medicine)

Education

Invited positions and distinctions

Ankara Üniversitesi: Ankara, Ankara, TR

Ophthalmologist, researcher (Bioretina Biyoteknoloji Inc. Technopolis)

Works

Ozmert E, Arslan U. Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results. Stem Cells Transl Med.

2023 Oct 5;12(10):631-650.

doi: 10.1093/stcltm/szad051. PMID: 37713598; PMCID: PMC10552690.

Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulation

Stem Cell Research & Therapy

2021-12 | Journal article

DOI: 10.1186/s13287-021-02577-2

Investigation of genotype–phenotype relationship in Turkish patients with inherited retinal disease by next generation sequencing

Ophthalmic Genetics

2021-11-02 | Journal article

DOI: 10.1080/13816810.2021.1952616

Evaluation of the effect of subtenon autologous platelet-rich plasma injections on visual functions in patients with retinitis pigmentosa

Regenerative Medicine

2021-02-23 | Journal article

DOI: 10.2217/rme-2020-0075

Management of retinitis pigmentosa by Wharton’s jelly-derived mesenchymal stem cells: prospective analysis of 1-year results

Stem Cell Research & Therapy

2020-12 | Journal article

DOI: 10.1186/s13287-020-01870-w

PMID: PMID: 32787913

Effect of autologous growth factors on apoptosis and thickness of the outer nuclear layer in an experimental retinal degeneration model

Growth Factors

2020-11-01 | Journal article

DOI: 10.1080/08977194.2021.1948842

Treatment of resistant chronic central serous chorioretinopathy via platelet-rich plasma with electromagnetic stimulation

Regenerative Medicine

2020-10-27 | Journal article

DOI: 10.2217/rme-2020-0056

PMID: 33107400

Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser.

Lasers in medical science

2020-05-04 | Journal article

PMID: 32363437

DOI: 10.1007/s10103-020-03031-0

Management of Retinitis Pigmentosa via Platelet-Rich Plasma or Combination with Electromagnetic Stimulation: Retrospective Analysis of 1-Year Results.

Advances in therapy

2020-04-18 | Journal article

PMID: 32303913

DOI: 10.1007/s12325-020-01308-y

Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results.

Stem cell research & therapy

2020-01-13 | Journal article

PMID: 31931872

PMC: PMC6958670

DOI: 10.1186/s13287-020-1549-6

Retinal Prostheses and Artificial Vision

Turkish journal of ophthalmology

2019-09-01 | Journal article

PMID: 31486609

PMC: PMC6761377

DOI: 10.4274/tjo.galenos.2019.44270

Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet-Rich Plasma: Preliminary Clinical Results.

Advances in therapy

2019-08-05 | Journal article

PMID: 31385285

DOI: 10.1007/s12325-019-01040-2

Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.

Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

2018-03-15 | Journal article

PMID: 29546474

DOI: 10.1007/s00417-018-3953-5

Dissociated vertical deviation and its relationship with time and type of surgery in infantile esotropia.

The British journal of ophthalmology

2010-06-01 | Journal article

PMID: 20508049

DOI: 10.1136/bjo.2008.157016

Peer review

Review activity for Stem cell research & therapy. (18)

Akademik yayın ve sunumlar:

Uluslararası Akademik Yayınlar için Tıklayınız

Bilimsel Araştırma Ödülleri

2020 ULUSAL OFTALMOLOJİ KONGRESİNDE TÜRK OFTALMOLOJİ DERNEĞİ TARAFINDAN İKİ DALDA BİLİMSEL ARAŞTIRMA ÖDÜLÜNE LAYIK GÖRÜLDÜK. DEĞERLİ JÜRİ ÜYELERİNE ŞÜKRANLARIMIZI ARZ EDERİZ.

2022 Türk Oftalmaoloji Derneği Nisan Kursunda 2021 yılı içinde yapılan yayın değerlendirmesinde “Metil alkol zehirlenmesine bağlı optik nöropati tedavisinde kök hücre ve Magnovision” ile ilgili yayınımız birincilik ödülü almıştır. Jüri üyelerine teşekkürlerimizi arz ederiz.

İletişim:

TEL: 0505 502 51 66

ADRES: NEORAMA İŞ MERKEZİ OFİS 56 KAT 11 YAŞAM CADDESİ NO 13 SÖĞÜTÖZÜ-BEŞTEPE/ANKARA